- Home
- UTMD vs BDTX Comparison
UTMD vs BDTX Comparison
Compare UTMD & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UTMD | BDTX |
|---|---|---|
| Founded | 1978 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 196.4M | 116.8M |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | UTMD | BDTX |
|---|---|---|
| Price | $63.27 | $2.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.40 |
| AVG Volume (30 Days) | 9.5K | ★ 561.6K |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.95% | N/A |
| EPS Growth | N/A | ★ 32.45 |
| EPS | ★ 2.68 | 0.65 |
| Revenue | ★ $40,903,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $23.79 | ★ $3.46 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $51.27 | $1.20 |
| 52 Week High | $68.71 | $4.94 |
Technical Indicators
Market Signals| Indicator | UTMD | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 42.35 | 41.13 |
| Support Level | $60.00 | N/A |
| Resistance Level | $64.21 | $2.67 |
| Average True Range (ATR) | 1.67 | 0.14 |
| MACD | -0.62 | -0.01 |
| Stochastic Oscillator | 11.79 | 28.17 |
Price Performance
Historical ComparisonAbout UTMD Utah Medical Products Inc.
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.